Biosynth’s unique online custom peptide toolset completed with full order tracking and QC data portal

FHS
June 28, 2024
4:41 pm

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution.

Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Patent 21-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

October 22, 2024

General Catalyst to buy Ohio-based health system Summa Health

Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health and reestablish it as a for-profit organization, the health system’s

January 17, 2024

Gut health linked to Alzheimer’s disease progression, experts urge dietary shift

The interactions between the gut microbiome, lipids, and Alzheimer’s disease (AD).

November 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.